With Vicept Buy, Allergan Gains Rosacea Treatment Under Development

Drug firm Allergan Inc. has a daily rosacea treatment in the development pipeline following its acquisition of privately held specialty biopharmaceutical firm Vicept Therapeutics in July.

More from Archive

More from HBW Insight